Synapse

← JHEP Reports

Papers in JHEP Reports

Page 1 · newest first

  1. The Liver–Heart Axis: Linking Liver Stiffness to Early Cardiac Dysfunction in MASLDJHEP Reports · 2026
  2. Prognostic role of the Child-Turcotte-Pugh classification and ALBI grade in patients without cirrhosis and hepatocellular carcinomaJHEP Reports · 2026
  3. Sex differences in MASLD and fitness improvement during a weight loss intervention for adolescents living with obesityJHEP Reports · 2026
  4. The landscape of hepatocellular carcinoma recurrence after liver transplantation: a nationwide 14-year studyJHEP Reports · 2026
  5. Rapid genetic testing and treatment of patients with severe and early onset intrahepatic cholestasis of pregnancyJHEP Reports · 2026
  6. Spatiotemporal Multi-Omics Reveals Primate-Specific Mechanisms of Liver Regeneration Following Partial HepatectomyJHEP Reports · 2026
  7. Beyond the class effect: Rethinking anticoagulation in liver diseaseJHEP Reports · 2026
  8. Perioperative strategies for the treatment of HCCJHEP Reports · 2026
  9. Autoimmune hepatitis: special groups and treatment gapsJHEP Reports · 2026
  10. Gender differences in stigma and care avoidance among people living with MASLD: an international surveyJHEP Reports · 2026
  11. Medical therapy of MASLD – consequences of the paradigm shift from histology to non-invasive testsJHEP Reports · 2026
  12. Hepatic encephalopathy in chronic liver disease: Emerging insights from the gut microbiomeJHEP Reports · 2026
  13. Immune metabolic reprogramming in MASLDJHEP Reports · 2026
  14. Spatial transcriptomics reveal impaired metabolic liver zonation in acute-on-chronic liver failureJHEP Reports · 2026
  15. Prevalence and Significance of Combined Low Muscle Volume and High Muscle Fat in Patients with Child–Pugh A-B CirrhosisJHEP Reports · 2026
  16. Chronic Liver Disease-Related Osteoporosis: From Mechanisms to Precision InterventionJHEP Reports · 2026
  17. Promises and Pitfalls of ctDNA testing in the Management of CholangiocarcinomaJHEP Reports · 2026
  18. Intestinal barrier dysfunction assessed by confocal laser endomicroscopy correlates with cirrhosis severity and clinical outcome☆JHEP Reports · 2026
  19. Anxiety and Depression in Liver Disease: Pathways, Prevalence, and Implications for Care – a ReviewJHEP Reports · 2026
  20. Aligned ELF and VCTE cutoffs facilitate risk staging in patients with metabolic dysfunction-associated steatohepatitisJHEP Reports · 2026
  21. Real-world data from patients treated with chemotherapy for biliary tract cancer: insights from a prognostic model. ☆JHEP Reports · 2026
  22. Intravital Imaging as a Tool to Uncover Roles of Immune Cells in Chronic Liver DiseasesJHEP Reports · 2026
  23. Screening for Metabolic Dysfunction-Associated Steatohepatitis in Adults with Type 2 Diabetes in the U.S. and 5 European Countries: A Cost-Utility AnalysisJHEP Reports · 2026
  24. Biomarkers associated with efficacy of first-line nivolumab vs. sorafenib in advanced hepatocellular carcinoma: results from the CheckMate 459 phase III trialJHEP Reports · 2026
  25. Novel 3D models for β-catenin-driven liver cancersJHEP Reports · 2026
  26. Hepatitis C RNA prevalence before and during broad access to direct-acting antivirals in people with HIV across six countriesJHEP Reports · 2026
  27. Body Roundness Index, MASLD risk and long-term follow-up outcomes among the general populationJHEP Reports · 2026
  28. Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinomaJHEP Reports · 2026
  29. HBsAg isoforms predict HBsAg seroclearance and finite treatment in patients with chronic hepatitis B after cessation of long-term nucleos(t)ide analogsJHEP Reports · 2026
  30. The impact of alcohol consumption on the risk of hepatocellular carcinoma across different age groups: A nationwide cohort studyJHEP Reports · 2026
  31. A Dynamic Prognostic and Adaptive Treatment Framework for Advanced Biliary Tract CancerJHEP Reports · 2026
  32. Combined anti-PD-1 with irreversible electroporation relieves immunosuppression and reduces hepatocellular carcinoma regrowthJHEP Reports · 2026
  33. Sleep Irregularity is Associated with Reduced Wellbeing in Patients with CirrhosisJHEP Reports · 2026
  34. Serum Receptor-Interacting Protein Kinase 3 (RIPK3) Is Associated with Transplant-Free Survival in Acute Liver FailureJHEP Reports · 2026
  35. Systemic Treatment Patterns and Clinical Outcomes in Hepatocellular Carcinoma: A Multicenter Real-World Study from China (STAR-HCC)JHEP Reports · 2026
  36. Diverging trends and persistent inequities in cirrhosis burden across sub-Saharan Africa: projections to 2040JHEP Reports · 2026
  37. Genome-scale CRISPR screening uncovers SRSF6 as a target to sensitize hepatocellular carcinoma to radiotherapyJHEP Reports · 2026
  38. The Circadian Clock controls Hepatic Inflammation in MASLDJHEP Reports · 2026
  39. Long-term outcome of sinusoidal obstruction syndrome secondary to hematopoietic stem cell transplantation.JHEP Reports · 2026
  40. Therapeutic vaccination strategy targeting the PreS1 region of L-HBsAg for HBV/HDV co-infectionJHEP Reports · 2026
  41. Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitisJHEP Reports · 2026
  42. MiR-122 regulates liver toleranceJHEP Reports · 2026
  43. Management of rare primary liver cancers: combined hepato-cholangiocarcinoma and fibrolamellar hepatocellular carcinomaJHEP Reports · 2026
  44. Clinical and Metabolomic Panel for Noninvasive Screening of Biopsy-Confirmed MASH in Children and AdolescentsJHEP Reports · 2026
  45. Targeting Circulating Fatty Acid Binding Protein 4 Ameliorates Obesity-Associated Hepatic SteatosisJHEP Reports · 2026
  46. Atezolizumab–Bevacizumab with or without Cisplatin-based HAIC for Unresectable HCC: A Randomized Phase 2 TrialJHEP Reports · 2026
  47. Risk Prediction Models for Hepatic Encephalopathy Post-Transjugular Intrahepatic Portosystemic Shunt: a Systematic Review and Critical Appraisal.JHEP Reports · 2026
  48. SREBP-driven lipogenesis coupled with ferroptosis resistance as a therapeutic target in PTEN-loss extrahepatic cholangiocarcinomaJHEP Reports · 2026
  49. Liver Transplantation at the Extreme: Analysis of Outcomes and Predictors of Futility in Acute-on-Chronic Liver Failure Grade 3 Patients on Maximal Life SupportJHEP Reports · 2026
  50. First Decompensation Outweighs Portal Vein Thrombosis in cACLD: Molecular Profiling and Derivation of the VAIL ScoreJHEP Reports · 2026